The term ‘take-home naloxone’ refers to a variety of life-saving initiatives in which a medication (naloxone) is made available to non-medically trained people for administration to others experiencing an opioid overdose. Despite a range of efforts to expand these initiatives over the last decade, the uptake of take-home naloxone in Australia remains inconsistent. This month…
Recruitment and interviewing for SSAC’s ARC-funded research on uptake and diffusion of take-home naloxone in Victoria and New South Wales are almost complete. After a successful recruitment period in Victoria, the SSAC team begun recruiting in NSW towards the end of 2017. The interviews with people who consume opioids and health professionals working in relevant…
Many thanks to those who have volunteered to be interviewed for SSAC’s project on ‘take-home’ naloxone in Australia. We have now begun interviewing health professionals in New South Wales about their experiences with and knowledge of opioids, overdose and take-home naloxone. We would like to interview: Pharmacotherapy prescribers Pain management specialists General practitioners Pharmacists Participation…
Many thanks to those who have volunteered to be interviewed for SSAC’s project on ‘take-home’ naloxone in Australia. We have now begun recruiting people who consume opioid medications to manage chronic pain living in New South Wales. Interviews will be conducted by Research Assistant, Dr Jeanne Ellard. If you are are interested in taking part,…
A team of researchers led by SSAC’s Professor Suzanne Fraser will begin work this month on a new project investigating impediments to uptake of ‘take-home’ naloxone in Australia. Entitled ‘Understanding the impediments to uptake and diffusion of take-home naloxone in Australia’, the project is funded by the Australian Research Council, and coordinated by research associate…
